dopamine: be used for bradycardia

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents neurotransmitter
Weight: 0.73
, chemical
Weight: 0.69
, hormone
Weight: 0.68
, neuron
Weight: 0.67
, drug
Weight: 0.67
Siblings acetylcholine
Weight: 0.41
, serotonin
Weight: 0.41
, vasopressin
Weight: 0.39
, oxytocin
Weight: 0.39
, norepinephrine
Weight: 0.38

Related properties

Property Similarity
be used for bradycardia 1.00
be contraindicated in pheochromocytoma 0.79
be used in acute renal failure 0.78
be contraindicated in hypovolemic shock 0.77
be used in neonates 0.77
be used in renal failure 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.26
Plausible(dopamine, be used for bradycardia)
Evidence: 0.26
¬ Salient(dopamine, be used for bradycardia)

Similarity expansion

0.57
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.77
Evidence: 0.36
Typical(dopamine, be used for bradycardia)
Evidence: 0.19
¬ Typical(dopamine, be used in neonates)
0.52
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.78
Evidence: 0.35
Remarkable(dopamine, be used for bradycardia)
Evidence: 0.34
¬ Remarkable(dopamine, be used in acute renal failure)
0.51
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.77
Evidence: 0.26
Plausible(dopamine, be used for bradycardia)
Evidence: 0.31
¬ Plausible(dopamine, be used in neonates)
0.49
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.76
Evidence: 0.26
Salient(dopamine, be used for bradycardia)
Evidence: 0.33
¬ Salient(dopamine, be used in renal failure)
0.49
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.76
Evidence: 0.35
Remarkable(dopamine, be used for bradycardia)
Evidence: 0.38
¬ Remarkable(dopamine, be used in renal failure)
0.49
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.78
Evidence: 0.26
Salient(dopamine, be used for bradycardia)
Evidence: 0.37
¬ Salient(dopamine, be used in acute renal failure)
0.47
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.76
Evidence: 0.26
Plausible(dopamine, be used for bradycardia)
Evidence: 0.36
¬ Plausible(dopamine, be used in renal failure)
0.46
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.77
Evidence: 0.26
Salient(dopamine, be used for bradycardia)
Evidence: 0.41
¬ Salient(dopamine, be used in neonates)
0.45
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.76
Evidence: 0.36
Typical(dopamine, be used for bradycardia)
Evidence: 0.47
¬ Typical(dopamine, be used in renal failure)
0.44
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.78
Evidence: 0.26
Plausible(dopamine, be used for bradycardia)
Evidence: 0.45
¬ Plausible(dopamine, be used in acute renal failure)
0.43
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.77
Evidence: 0.36
Typical(dopamine, be used for bradycardia)
Evidence: 0.55
¬ Typical(dopamine, be contraindicated in hypovolemic shock)
0.42
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.79
Evidence: 0.36
Typical(dopamine, be used for bradycardia)
Evidence: 0.59
¬ Typical(dopamine, be contraindicated in pheochromocytoma)
0.41
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.78
Evidence: 0.36
Typical(dopamine, be used for bradycardia)
Evidence: 0.59
¬ Typical(dopamine, be used in acute renal failure)
0.41
Rule weight: 0.85
Evidence weight: 0.61
Similarity weight: 0.79
Evidence: 0.35
Remarkable(dopamine, be used for bradycardia)
Evidence: 0.61
¬ Remarkable(dopamine, be contraindicated in pheochromocytoma)
0.39
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.79
Evidence: 0.26
Plausible(dopamine, be used for bradycardia)
Evidence: 0.56
¬ Plausible(dopamine, be contraindicated in pheochromocytoma)
0.36
Rule weight: 0.85
Evidence weight: 0.55
Similarity weight: 0.77
Evidence: 0.26
Plausible(dopamine, be used for bradycardia)
Evidence: 0.60
¬ Plausible(dopamine, be contraindicated in hypovolemic shock)
0.36
Rule weight: 0.85
Evidence weight: 0.54
Similarity weight: 0.79
Evidence: 0.26
Salient(dopamine, be used for bradycardia)
Evidence: 0.63
¬ Salient(dopamine, be contraindicated in pheochromocytoma)
0.32
Rule weight: 0.85
Evidence weight: 0.49
Similarity weight: 0.77
Evidence: 0.35
Remarkable(dopamine, be used for bradycardia)
Evidence: 0.78
¬ Remarkable(dopamine, be used in neonates)
0.32
Rule weight: 0.85
Evidence weight: 0.49
Similarity weight: 0.77
Evidence: 0.35
Remarkable(dopamine, be used for bradycardia)
Evidence: 0.78
¬ Remarkable(dopamine, be contraindicated in hypovolemic shock)
0.29
Rule weight: 0.85
Evidence weight: 0.44
Similarity weight: 0.77
Evidence: 0.26
Salient(dopamine, be used for bradycardia)
Evidence: 0.75
¬ Salient(dopamine, be contraindicated in hypovolemic shock)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.26
Salient(dopamine, be used for bradycardia)
Evidence: 0.36
¬ Typical(dopamine, be used for bradycardia)
Evidence: 0.35
¬ Remarkable(dopamine, be used for bradycardia)

Typical implies Plausible

0.35
Rule weight: 0.48
Evidence weight: 0.73
Similarity weight: 1.00
Evidence: 0.26
Plausible(dopamine, be used for bradycardia)
Evidence: 0.36
¬ Typical(dopamine, be used for bradycardia)